These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
107 related items for PubMed ID: 24045262
1. Factors affecting 18F-FDG uptake by metastatic lymph nodes in gastric cancer. Kim YH, Choi JY, Do IG, Kim S, Kim BT. J Comput Assist Tomogr; 2013; 37(5):815-9. PubMed ID: 24045262 [Abstract] [Full Text] [Related]
3. High correlations between primary tumours and loco-regional metastatic lymph nodes in non-small-cell lung cancer with respect to glucose transporter type 1-mediated 2-deoxy-2-F18-fluoro-D-glucose uptake. Nguyen XC, So Y, Chung JH, Lee WW, Park SY, Kim SE. Eur J Cancer; 2008 Mar; 44(5):692-8. PubMed ID: 18314327 [Abstract] [Full Text] [Related]
5. Lymph node staging of gastric cancer using (18)F-FDG PET: a comparison study with CT. Yun M, Lim JS, Noh SH, Hyung WJ, Cheong JH, Bong JK, Cho A, Lee JD. J Nucl Med; 2005 Oct; 46(10):1582-8. PubMed ID: 16204706 [Abstract] [Full Text] [Related]
6. Integrated FDG-PET/CT compared with intravenous contrast-enhanced CT for evaluation of metastatic regional lymph nodes in patients with resectable early stage esophageal cancer. Okada M, Murakami T, Kumano S, Kuwabara M, Shimono T, Hosono M, Shiozaki H. Ann Nucl Med; 2009 Jan; 23(1):73-80. PubMed ID: 19205841 [Abstract] [Full Text] [Related]
7. Evaluation of 18F-FDG uptake for detecting lymph node metastasis of gastric cancer: a prospective pilot study for one-to-one comparison of radiation dose and pathological findings. Okumura Y, Aikou S, Onoyama H, Jinbo K, Yamagata Y, Mori K, Yamashita H, Nomura S, Takahashi M, Koyama K, Momose T, Abe H, Matsusaka K, Ushiku T, Fukayama M, Seto Y. World J Surg Oncol; 2015 Dec 02; 13():327. PubMed ID: 26628257 [Abstract] [Full Text] [Related]
8. 18F-FDG uptake by primary tumor as a predictor of intratumoral lymphatic vessel invasion and lymph node involvement in non-small cell lung cancer: analysis of a multicenter study. Higashi K, Ito K, Hiramatsu Y, Ishikawa T, Sakuma T, Matsunari I, Kuga G, Miura K, Higuchi T, Tonami H, Yamamoto I. J Nucl Med; 2005 Feb 02; 46(2):267-73. PubMed ID: 15695786 [Abstract] [Full Text] [Related]
10. 18F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression. Yen TC, See LC, Lai CH, Yah-Huei CW, Ng KK, Ma SY, Lin WJ, Chen JT, Chen WJ, Lai CR, Hsueh S. J Nucl Med; 2004 Jan 02; 45(1):22-9. PubMed ID: 14734665 [Abstract] [Full Text] [Related]
11. Metabolic response of lymph nodes immediately after RT is related with survival outcome of patients with pelvic node-positive cervical cancer using consecutive [18F]fluorodeoxyglucose-positron emission tomography/computed tomography. Yoon MS, Ahn SJ, Nah BS, Chung WK, Song HC, Yoo SW, Song JY, Jeong JU, Nam TK. Int J Radiat Oncol Biol Phys; 2012 Nov 15; 84(4):e491-7. PubMed ID: 22818418 [Abstract] [Full Text] [Related]
12. ¹⁸FDG PET for grading malignancy in thymic epithelial tumors: significant differences in ¹⁸FDG uptake and expression of glucose transporter-1 and hexokinase II between low and high-risk tumors: preliminary study. Nakajo M, Kajiya Y, Tani A, Yoneda S, Shirahama H, Higashi M, Nakajo M. Eur J Radiol; 2012 Jan 15; 81(1):146-51. PubMed ID: 20810231 [Abstract] [Full Text] [Related]
13. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours. Toba H, Kondo K, Sadohara Y, Otsuka H, Morimoto M, Kajiura K, Nakagawa Y, Yoshida M, Kawakami Y, Takizawa H, Kenzaki K, Sakiyama S, Bando Y, Tangoku A. Eur J Cardiothorac Surg; 2013 Aug 15; 44(2):e105-12. PubMed ID: 23674658 [Abstract] [Full Text] [Related]
14. 18F-FDG uptake in reactive neck lymph nodes of oral cancer: relationship to lymphoid follicles. Nakagawa T, Yamada M, Suzuki Y. J Nucl Med; 2008 Jul 15; 49(7):1053-9. PubMed ID: 18587087 [Abstract] [Full Text] [Related]
16. Axillary lymph node characterization in breast cancer patients using magnetic resonance mammography: a prospective comparative study with FDG PET-CT and healthy women. Krammer J, Wasser K, Schnitzer A, Henzler T, Schoenberg SO, Kaiser CG. Eur J Radiol; 2013 Dec 15; 82(12):2194-8. PubMed ID: 23993142 [Abstract] [Full Text] [Related]
17. Preliminary report of using FDG-PET to detect extrapelvic lesions in cervical cancer patients with enlarged pelvic lymph nodes on MRI/CT. Tsai CS, Chang TC, Lai CH, Tsai CC, Ng KK, Hsueh S, Yen TC, Hong JH. Int J Radiat Oncol Biol Phys; 2004 Apr 01; 58(5):1506-12. PubMed ID: 15050330 [Abstract] [Full Text] [Related]
18. 18F-FDG-PET of musculoskeletal tumors: a correlation with the expression of glucose transporter 1 and hexokinase II. Hamada K, Tomita Y, Qiu Y, Zhang B, Ueda T, Myoui A, Higuchi I, Yoshikawa H, Aozasa K, Hatazawa J. Ann Nucl Med; 2008 Oct 01; 22(8):699-705. PubMed ID: 18982473 [Abstract] [Full Text] [Related]
19. Variable 18F-fluorodeoxyglucose uptake in gastric cancer is associated with different levels of GLUT-1 expression. Alakus H, Batur M, Schmidt M, Drebber U, Baldus SE, Vallböhmer D, Prenzel KL, Metzger R, Bollschweiler E, Hölscher AH, Mönig SP. Nucl Med Commun; 2010 Jun 01; 31(6):532-8. PubMed ID: 20220543 [Abstract] [Full Text] [Related]